These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9054631)

  • 41. Comparison of chromium III and VI toxicities in water using sulfur-oxidizing bacterial bioassays.
    Qambrani NA; Hwang JH; Oh SE
    Chemosphere; 2016 Oct; 160():342-8. PubMed ID: 27393970
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of HMG protein binding to DNA modified with the anticancer drug cisplatin.
    Cryer JE; Johnson SW; Engelsberg BN; Billings PC
    Cancer Chemother Pharmacol; 1996; 38(2):163-8. PubMed ID: 8616907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential sensitivity of chromium-mediated DNA interstrand crosslinks and DNA-protein crosslinks to disruption by alkali and EDTA.
    Singh J; Bridgewater LC; Patierno SR
    Toxicol Sci; 1998 Sep; 45(1):72-6. PubMed ID: 9848113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNA.
    Dunham SU; Lippard SJ
    Biochemistry; 1997 Sep; 36(38):11428-36. PubMed ID: 9298962
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-mobility group 1 protein inhibits helicase catalyzed displacement of cisplatin-damaged DNA.
    Patrick SM; Henkels KM; Turchi JJ
    Biochim Biophys Acta; 1997 Nov; 1354(3):279-90. PubMed ID: 9427537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
    Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
    Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of the acidic tail on the DNA-binding properties of the HMG1,2 class of proteins: insights from tail switching and tail removal.
    Lee KB; Thomas JO
    J Mol Biol; 2000 Nov; 304(2):135-49. PubMed ID: 11080451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding of tsHMG, a mouse testis-specific HMG-domain protein, to cisplatin-DNA adducts.
    Ohndorf UM; Whitehead JP; Raju NL; Lippard SJ
    Biochemistry; 1997 Dec; 36(48):14807-15. PubMed ID: 9398202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bacterial Cr(VI) reduction concurrently improves sunflower (Helianthus Annuus L.) growth.
    Faisal M; Hasnain S
    Biotechnol Lett; 2005 Jul; 27(13):943-7. PubMed ID: 16091890
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microprobe X-ray absorption spectroscopic determination of the oxidation state of intracellular chromium following exposure of V79 Chinese hamster lung cells to genotoxic chromium complexes.
    Dillon CT; Lay PA; Cholewa M; Legge GJ; Bonin AM; Collins TJ; Kostka KL; Shea-McCarthy G
    Chem Res Toxicol; 1997 May; 10(5):533-5. PubMed ID: 9168250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-enzymatic phosphorylation of bovine serum albumin by Cr(V) complexes: role in Cr(VI)-induced phosphorylation and toxicity.
    Vasant C; Sankaramanivel S; Jana M; Rajaram R; Ramasami T
    Mol Cell Biochem; 2005 Jul; 275(1-2):153-64. PubMed ID: 16335795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Apoptosis of lymphocytes in the presence of Cr(V) complexes: role in Cr(VI)-induced toxicity.
    Vasant C; Balamurugan K; Rajaram R; Ramasami T
    Biochem Biophys Res Commun; 2001 Aug; 285(5):1354-60. PubMed ID: 11478807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Binding of Ixr1, a yeast HMG-domain protein, to cisplatin-DNA adducts in vitro and in vivo.
    McA'Nulty MM; Whitehead JP; Lippard SJ
    Biochemistry; 1996 May; 35(19):6089-99. PubMed ID: 8634251
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of DNA synthesis by chromium compounds.
    Nishio A; Uyeki EM
    J Toxicol Environ Health; 1985; 15(2):237-44. PubMed ID: 3892022
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduction of Cr (VI) by cysteine: significance in human lymphocytes and formation of DNA damage in reactions with variable reduction rates.
    Quievryn G; Goulart M; Messer J; Zhitkovich A
    Mol Cell Biochem; 2001 Jun; 222(1-2):107-18. PubMed ID: 11678591
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of mutagenic DNA damage by chromium (VI) and glutathione.
    Liu S; Dixon K
    Environ Mol Mutagen; 1996; 28(2):71-9. PubMed ID: 8844987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Difference in affinity for DNA between HMG proteins 1 and 2 determined by surface plasmon resonance measurements.
    Yamamoto A; Ando Y; Yoshioka K; Saito K; Tanabe T; Shirakawa H; Yoshida M
    J Biochem; 1997 Sep; 122(3):586-94. PubMed ID: 9348088
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interactions between chromium(III) and iron(III), molybdenum(III) or nickel(II): Cytotoxicity, genotoxicity and mutagenicity studies.
    Terpilowska S; Siwicki AK
    Chemosphere; 2018 Jun; 201():780-789. PubMed ID: 29550572
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.
    Huang JC; Zamble DB; Reardon JT; Lippard SJ; Sancar A
    Proc Natl Acad Sci U S A; 1994 Oct; 91(22):10394-8. PubMed ID: 7937961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Performance and glucose metabolism in calves fed a chromium-nicotinic acid complex or chromium chloride.
    Kegley EB; Spears JW; Eisemann JH
    J Dairy Sci; 1997 Aug; 80(8):1744-50. PubMed ID: 9276815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.